ODDITY Tech (NASDAQ:ODD – Get Free Report) and Dermata Therapeutics (NASDAQ:DRMA – Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, institutional ownership, valuation and profitability.
Institutional and Insider Ownership
35.9% of ODDITY Tech shares are owned by institutional investors. Comparatively, 8.7% of Dermata Therapeutics shares are owned by institutional investors. 21.9% of Dermata Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Volatility and Risk
ODDITY Tech has a beta of 2.38, meaning that its stock price is 138% more volatile than the S&P 500. Comparatively, Dermata Therapeutics has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| ODDITY Tech | $809.84 million | 0.92 | $110.75 million | $0.79 | 16.33 |
| Dermata Therapeutics | N/A | N/A | -$7.56 million | ($4.39) | -0.31 |
ODDITY Tech has higher revenue and earnings than Dermata Therapeutics. Dermata Therapeutics is trading at a lower price-to-earnings ratio than ODDITY Tech, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares ODDITY Tech and Dermata Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ODDITY Tech | 6.97% | 15.38% | 4.99% |
| Dermata Therapeutics | N/A | -151.26% | -123.05% |
Analyst Ratings
This is a breakdown of current recommendations for ODDITY Tech and Dermata Therapeutics, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ODDITY Tech | 4 | 9 | 0 | 0 | 1.69 |
| Dermata Therapeutics | 1 | 0 | 1 | 0 | 2.00 |
ODDITY Tech presently has a consensus target price of $25.39, indicating a potential upside of 96.79%. Dermata Therapeutics has a consensus target price of $10.00, indicating a potential upside of 624.64%. Given Dermata Therapeutics’ stronger consensus rating and higher possible upside, analysts clearly believe Dermata Therapeutics is more favorable than ODDITY Tech.
Summary
ODDITY Tech beats Dermata Therapeutics on 9 of the 13 factors compared between the two stocks.
About ODDITY Tech
Oddity Tech Ltd. operates as a consumer tech company that builds digital-first brands for the beauty and wellness industries in the United States and internationally. It serves consumers worldwide through its AI-driven online platform, which uses data science, machine learning, and computer vision capabilities to identify consumer needs, and develop solutions in the form of beauty and wellness products. The company sells beauty, hair, and skin products under the IL MAKIAGE and SpoiledChild brands. In addition, it operates ODDITY LABS, a biotechnology center, which develops various ingredients, including novel molecules, probiotics, and peptides for beauty and wellness products. Oddity Tech Ltd. was incorporated in 2013 and is headquartered in Tel Aviv, Israel.
About Dermata Therapeutics
Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Receive News & Ratings for ODDITY Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ODDITY Tech and related companies with MarketBeat.com's FREE daily email newsletter.
